Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 86 entries
Sorted by: Best Match Show Resources per page
Rays Sting: The Acute Cellular Effects of Ionizing Radiation Exposure.

Translational medicine @ UniSa

Franco A, Ciccarelli M, Sorriento D, Napolitano L, Fiordelisi A, Trimarco B, Durante M, Iaccarino G.
PMID: 27326395
Transl Med UniSa. 2016 May 16;14:42-53. eCollection 2016 May.

High-precision radiation therapy is a clinical approach that uses the targeted delivery of ionizing radiation, and the subsequent formation of reactive oxygen species (ROS) in high proliferative, radiation sensitive cancers. In particular, in thoracic cancer ratdiation treatments, can not...

Cite
Franco A, Ciccarelli M, Sorriento D, et al. Rays Sting: The Acute Cellular Effects of Ionizing Radiation Exposure. Transl Med UniSa. 2016;14:42-53
Franco, A., Ciccarelli, M., Sorriento, D., Napolitano, L., Fiordelisi, A., Trimarco, B., Durante, M., & Iaccarino, G. (2016). Rays Sting: The Acute Cellular Effects of Ionizing Radiation Exposure. Translational medicine @ UniSa, 1442-53.
Franco, A, et al. "Rays Sting: The Acute Cellular Effects of Ionizing Radiation Exposure." Translational medicine @ UniSa vol. 14 (2016): 42-53.
Franco A, Ciccarelli M, Sorriento D, Napolitano L, Fiordelisi A, Trimarco B, Durante M, Iaccarino G. Rays Sting: The Acute Cellular Effects of Ionizing Radiation Exposure. Transl Med UniSa. 2016 May 16;14:42-53. eCollection 2016 May. PMID: 27326395; PMCID: PMC4912338.
Copy Download .nbib Format: NLM
Fast and sensitive method for detecting volatile species in liquids.

The Review of scientific instruments

Trimarco DB, Pedersen T, Hansen O, Chorkendorff I, Vesborg PC.
PMID: 26233407
Rev Sci Instrum. 2015 Jul;86(7):075006. doi: 10.1063/1.4923453.

This paper presents a novel apparatus for extracting volatile species from liquids using a "sniffer-chip." By ultrafast transfer of the volatile species through a perforated and hydrophobic membrane into an inert carrier gas stream, the sniffer-chip is able to...

Cite
Trimarco DB, Pedersen T, Hansen O, et al. Fast and sensitive method for detecting volatile species in liquids. Rev Sci Instrum. 2015;86(7):075006doi: 10.1063/1.4923453.
Trimarco, D. B., Pedersen, T., Hansen, O., Chorkendorff, I., & Vesborg, P. C. (2015). Fast and sensitive method for detecting volatile species in liquids. The Review of scientific instruments, 86(7), 075006. https://doi.org/10.1063/1.4923453
Trimarco, Daniel B, et al. "Fast and sensitive method for detecting volatile species in liquids." The Review of scientific instruments vol. 86,7 (2015): 075006. doi: https://doi.org/10.1063/1.4923453
Trimarco DB, Pedersen T, Hansen O, Chorkendorff I, Vesborg PC. Fast and sensitive method for detecting volatile species in liquids. Rev Sci Instrum. 2015 Jul;86(7):075006. doi: 10.1063/1.4923453. PMID: 26233407.
Copy Download .nbib Format: NLM
Early surgery after coronary revascularization: a fine line between bleeding and thrombosis.

Translational medicine @ UniSa

De Biase C, Capuano E, De Luca S, D'Anna C, Luciano R, Piscione F, Trimarco B, Galasso G.
PMID: 25674544
Transl Med UniSa. 2014 Dec 19;11:14-23. eCollection 2015.

Management of PCI patients undergoing early surgery is still a matter of debate. Noteworthy, PCI patients require a dual antiplatelet therapy (DAPT), with aspirine and a thienopiridine (clopidogrel, prasugrel, ticagrelor), because of the high risk of stent thrombosis (ST),...

Cite
De Biase C, Capuano E, De Luca S, et al. Early surgery after coronary revascularization: a fine line between bleeding and thrombosis. Transl Med UniSa. 2014;11:14-23
De Biase, C., Capuano, E., De Luca, S., D'Anna, C., Luciano, R., Piscione, F., Trimarco, B., & Galasso, G. (2015). Early surgery after coronary revascularization: a fine line between bleeding and thrombosis. Translational medicine @ UniSa, 1114-23.
De Biase, C, et al. "Early surgery after coronary revascularization: a fine line between bleeding and thrombosis." Translational medicine @ UniSa vol. 11 (2015): 14-23.
De Biase C, Capuano E, De Luca S, D'Anna C, Luciano R, Piscione F, Trimarco B, Galasso G. Early surgery after coronary revascularization: a fine line between bleeding and thrombosis. Transl Med UniSa. 2014 Dec 19;11:14-23. eCollection 2015. PMID: 25674544; PMCID: PMC4309650.
Copy Download .nbib Format: NLM
Calcium release channel RyR2 regulates insulin release and glucose homeostasis.

The Journal of clinical investigation

Santulli G, Pagano G, Sardu C, Xie W, Reiken S, D'Ascia SL, Cannone M, Marziliano N, Trimarco B, Guise TA, Lacampagne A, Marks AR.
PMID: 26524594
J Clin Invest. 2015 Nov 02;125(11):4316. doi: 10.1172/JCI84937. Epub 2015 Nov 02.

No abstract available.

Cite
Santulli G, Pagano G, Sardu C, et al. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest. 2015;125(11):4316doi: 10.1172/JCI84937.
Santulli, G., Pagano, G., Sardu, C., Xie, W., Reiken, S., D'Ascia, S. L., Cannone, M., Marziliano, N., Trimarco, B., Guise, T. A., Lacampagne, A., & Marks, A. R. (2015). Calcium release channel RyR2 regulates insulin release and glucose homeostasis. The Journal of clinical investigation, 125(11), 4316. https://doi.org/10.1172/JCI84937
Santulli, Gaetano, et al. "Calcium release channel RyR2 regulates insulin release and glucose homeostasis." The Journal of clinical investigation vol. 125,11 (2015): 4316. doi: https://doi.org/10.1172/JCI84937
Santulli G, Pagano G, Sardu C, Xie W, Reiken S, D'Ascia SL, Cannone M, Marziliano N, Trimarco B, Guise TA, Lacampagne A, Marks AR. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest. 2015 Nov 02;125(11):4316. doi: 10.1172/JCI84937. Epub 2015 Nov 02. PMID: 26524594; PMCID: PMC4639985.
Copy Download .nbib Format: NLM
Vitamin C and Cardiovascular Disease: An Update.

Antioxidants (Basel, Switzerland)

Morelli MB, Gambardella J, Castellanos V, Trimarco V, Santulli G.
PMID: 33287462
Antioxidants (Basel). 2020 Dec 03;9(12). doi: 10.3390/antiox9121227.

The potential beneficial effects of the antioxidant properties of vitamin C have been investigated in a number of pathological conditions. In this review, we assess both clinical and preclinical studies evaluating the role of vitamin C in cardiac and...

Cite
Morelli MB, Gambardella J, Castellanos V, et al. Vitamin C and Cardiovascular Disease: An Update. Antioxidants (Basel). 2020;9(12)doi: 10.3390/antiox9121227.
Morelli, M. B., Gambardella, J., Castellanos, V., Trimarco, V., & Santulli, G. (2020). Vitamin C and Cardiovascular Disease: An Update. Antioxidants (Basel, Switzerland), 9(12), . https://doi.org/10.3390/antiox9121227
Morelli, Marco B, et al. "Vitamin C and Cardiovascular Disease: An Update." Antioxidants (Basel, Switzerland) vol. 9,12 (2020). doi: https://doi.org/10.3390/antiox9121227
Morelli MB, Gambardella J, Castellanos V, Trimarco V, Santulli G. Vitamin C and Cardiovascular Disease: An Update. Antioxidants (Basel). 2020 Dec 03;9(12). doi: 10.3390/antiox9121227. PMID: 33287462; PMCID: PMC7761826.
Copy Download .nbib Format: NLM
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment.

Cancers

Severin F, Frezzato F, Visentin A, Martini V, Trimarco V, Carraro S, Tibaldi E, Brunati AM, Piazza F, Semenzato G, Facco M, Trentin L.
PMID: 31817171
Cancers (Basel). 2019 Dec 04;11(12). doi: 10.3390/cancers11121939.

The bone marrow microenvironment promotes proliferation and drug resistance in chronic lymphocytic leukemia (CLL). Although ibrutinib is active in CLL, it is rarely able to clear leukemic cells protected by bone marrow mesenchymal stromal cells (BMSCs) within the marrow...

Cite
Severin F, Frezzato F, Visentin A, et al. In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment. Cancers (Basel). 2019;11(12)doi: 10.3390/cancers11121939.
Severin, F., Frezzato, F., Visentin, A., Martini, V., Trimarco, V., Carraro, S., Tibaldi, E., Brunati, A. M., Piazza, F., Semenzato, G., Facco, M., & Trentin, L. (2019). In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment. Cancers, 11(12), . https://doi.org/10.3390/cancers11121939
Severin, Filippo, et al. "In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment." Cancers vol. 11,12 (2019). doi: https://doi.org/10.3390/cancers11121939
Severin F, Frezzato F, Visentin A, Martini V, Trimarco V, Carraro S, Tibaldi E, Brunati AM, Piazza F, Semenzato G, Facco M, Trentin L. In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment. Cancers (Basel). 2019 Dec 04;11(12). doi: 10.3390/cancers11121939. PMID: 31817171; PMCID: PMC6966457.
Copy Download .nbib Format: NLM
Corrigendum: Physiology of Highly Radioresistant .

Frontiers in microbiology

Bruckbauer ST, Martin J, Minkoff BB, Veling MT, Lancaster I, Liu J, Trimarco JD, Bushnell B, Lipzen A, Wood EA, Sussman MR, Pennacchio C, Cox MM.
PMID: 33362755
Front Microbiol. 2020 Dec 11;11:617806. doi: 10.3389/fmicb.2020.617806. eCollection 2020.

[This corrects the article DOI: 10.3389/fmicb.2020.582590.].

Cite
Bruckbauer ST, Martin J, Minkoff BB, et al. Corrigendum: Physiology of Highly Radioresistant . Front Microbiol. 2020;11:617806doi: 10.3389/fmicb.2020.617806.
Bruckbauer, S. T., Martin, J., Minkoff, B. B., Veling, M. T., Lancaster, I., Liu, J., Trimarco, J. D., Bushnell, B., Lipzen, A., Wood, E. A., Sussman, M. R., Pennacchio, C., & Cox, M. M. (2020). Corrigendum: Physiology of Highly Radioresistant . Frontiers in microbiology, 11617806. https://doi.org/10.3389/fmicb.2020.617806
Bruckbauer, Steven T, et al. "Corrigendum: Physiology of Highly Radioresistant ." Frontiers in microbiology vol. 11 (2020): 617806. doi: https://doi.org/10.3389/fmicb.2020.617806
Bruckbauer ST, Martin J, Minkoff BB, Veling MT, Lancaster I, Liu J, Trimarco JD, Bushnell B, Lipzen A, Wood EA, Sussman MR, Pennacchio C, Cox MM. Corrigendum: Physiology of Highly Radioresistant . Front Microbiol. 2020 Dec 11;11:617806. doi: 10.3389/fmicb.2020.617806. eCollection 2020. PMID: 33362755; PMCID: PMC7761467.
Copy Download .nbib Format: NLM
Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy.

Journal of clinical medicine

Bellis A, Di Gioia G, Mauro C, Mancusi C, Barbato E, Izzo R, Trimarco B, Morisco C.
PMID: 34279451
J Clin Med. 2021 Jul 01;10(13). doi: 10.3390/jcm10132968.

The significant reduction in 'ischemic time' through capillary diffusion of primary percutaneous intervention (pPCI) has rendered myocardial-ischemia reperfusion injury (MIRI) prevention a major issue in order to improve the prognosis of ST elevation myocardial infarction (STEMI) patients. In fact,...

Cite
Bellis A, Di Gioia G, Mauro C, et al. Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy. J Clin Med. 2021;10(13)doi: 10.3390/jcm10132968.
Bellis, A., Di Gioia, G., Mauro, C., Mancusi, C., Barbato, E., Izzo, R., Trimarco, B., & Morisco, C. (2021). Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy. Journal of clinical medicine, 10(13), . https://doi.org/10.3390/jcm10132968
Bellis, Alessandro, et al. "Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy." Journal of clinical medicine vol. 10,13 (2021). doi: https://doi.org/10.3390/jcm10132968
Bellis A, Di Gioia G, Mauro C, Mancusi C, Barbato E, Izzo R, Trimarco B, Morisco C. Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy. J Clin Med. 2021 Jul 01;10(13). doi: 10.3390/jcm10132968. PMID: 34279451; PMCID: PMC8268641.
Copy Download .nbib Format: NLM
Cortico-Cerebellar Hyper-Connections and Reduced Purkinje Cells Behind Abnormal Eyeblink Conditioning in a Computational Model of Autism Spectrum Disorder.

Frontiers in systems neuroscience

Trimarco E, Mirino P, Caligiore D.
PMID: 34975423
Front Syst Neurosci. 2021 Dec 17;15:666649. doi: 10.3389/fnsys.2021.666649. eCollection 2021.

Empirical evidence suggests that children with autism spectrum disorder (ASD) show abnormal behavior during delay eyeblink conditioning. They show a higher conditioned response learning rate and earlier peak latency of the conditioned response signal. The neuronal mechanisms underlying this...

Cite
Trimarco E, Mirino P, Caligiore D. Cortico-Cerebellar Hyper-Connections and Reduced Purkinje Cells Behind Abnormal Eyeblink Conditioning in a Computational Model of Autism Spectrum Disorder. Front Syst Neurosci. 2021;15:666649doi: 10.3389/fnsys.2021.666649.
Trimarco, E., Mirino, P., & Caligiore, D. (2021). Cortico-Cerebellar Hyper-Connections and Reduced Purkinje Cells Behind Abnormal Eyeblink Conditioning in a Computational Model of Autism Spectrum Disorder. Frontiers in systems neuroscience, 15666649. https://doi.org/10.3389/fnsys.2021.666649
Trimarco, Emiliano, et al. "Cortico-Cerebellar Hyper-Connections and Reduced Purkinje Cells Behind Abnormal Eyeblink Conditioning in a Computational Model of Autism Spectrum Disorder." Frontiers in systems neuroscience vol. 15 (2021): 666649. doi: https://doi.org/10.3389/fnsys.2021.666649
Trimarco E, Mirino P, Caligiore D. Cortico-Cerebellar Hyper-Connections and Reduced Purkinje Cells Behind Abnormal Eyeblink Conditioning in a Computational Model of Autism Spectrum Disorder. Front Syst Neurosci. 2021 Dec 17;15:666649. doi: 10.3389/fnsys.2021.666649. eCollection 2021. PMID: 34975423; PMCID: PMC8719301.
Copy Download .nbib Format: NLM
[Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy].

Giornale italiano di cardiologia (2006)

Battistoni A, Gallo G, Aragona CO, Barchiesi F, Basolo A, Bellone S, Bellotti P, Bertolotti M, Bianco A, Biffi A, Borghi C, Cicero AFG, Consoli A, Corsini A, Desideri G, Di Giacinto B, Fernando F, Ferri C, Galiuto L, Grassi D, Grassi G, Icardi G, Indolfi C, Lodi E, Modena MG, Muiesan ML, Nati G, Orsi A, Palermi S, Parati G, Passantino A, Patelli A, Pelliccia A, Pengo M, Filardi PP, Perseghin G, Pirro M, Pontremoli R, Rengo G, Ricotti R, Rizzoni D, Rocca B, Rotella C, Rubattu S, Salvetti G, Sciacqua A, Serdoz A, Sirico F, Squeo MR, Tocci G, Trimarco B, Vigili de Kreutzenberg S, Volpe R, Volpe M.
PMID: 34741593
G Ital Cardiol (Rome). 2021 May;22(5):1-105. doi: 10.1714/3605.35841.

No abstract available.

Cite
Battistoni A, Gallo G, Aragona CO, et al. Prevenzione Italia 2021
Un update del Documento di consenso
e raccomandazioni per la prevenzione
cardiovascolare in Italia. [Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]. G Ital Cardiol (Rome). 2021;22(5):1-105doi: 10.1714/3605.35841.
Battistoni, A., Gallo, G., Aragona, C. O., Barchiesi, F., Basolo, A., Bellone, S., Bellotti, P., Bertolotti, M., Bianco, A., Biffi, A., Borghi, C., Cicero, A. F. G., Consoli, A., Corsini, A., Desideri, G., Di Giacinto, B., Fernando, F., Ferri, C., Galiuto, L., Grassi, D., Grassi, G., Icardi, G., Indolfi, C., Lodi, E., Modena, M. G., Muiesan, M. L., Nati, G., Orsi, A., Palermi, S., Parati, G., Passantino, A., Patelli, A., Pelliccia, A., Pengo, M., Filardi, P. P., Perseghin, G., Pirro, M., Pontremoli, R., Rengo, G., Ricotti, R., Rizzoni, D., Rocca, B., Rotella, C., Rubattu, S., Salvetti, G., Sciacqua, A., Serdoz, A., Sirico, F., Squeo, M. R., Tocci, G., Trimarco, B., Vigili de Kreutzenberg, S., Volpe, R., & Volpe, M. (2021). Prevenzione Italia 2021
Un update del Documento di consenso
e raccomandazioni per la prevenzione
cardiovascolare in Italia. [Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]. Giornale italiano di cardiologia (2006), 22(5), 1-105. https://doi.org/10.1714/3605.35841
Battistoni, Allegra, et al. "Prevenzione Italia 2021
Un update del Documento di consenso
e raccomandazioni per la prevenzione
cardiovascolare in Italia." [Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]. Giornale italiano di cardiologia (2006) vol. 22,5 (2021): 1-105. doi: https://doi.org/10.1714/3605.35841
Battistoni A, Gallo G, Aragona CO, Barchiesi F, Basolo A, Bellone S, Bellotti P, Bertolotti M, Bianco A, Biffi A, Borghi C, Cicero AFG, Consoli A, Corsini A, Desideri G, Di Giacinto B, Fernando F, Ferri C, Galiuto L, Grassi D, Grassi G, Icardi G, Indolfi C, Lodi E, Modena MG, Muiesan ML, Nati G, Orsi A, Palermi S, Parati G, Passantino A, Patelli A, Pelliccia A, Pengo M, Filardi PP, Perseghin G, Pirro M, Pontremoli R, Rengo G, Ricotti R, Rizzoni D, Rocca B, Rotella C, Rubattu S, Salvetti G, Sciacqua A, Serdoz A, Sirico F, Squeo MR, Tocci G, Trimarco B, Vigili de Kreutzenberg S, Volpe R, Volpe M. Prevenzione Italia 2021
Un update del Documento di consenso
e raccomandazioni per la prevenzione
cardiovascolare in Italia. [Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]. G Ital Cardiol (Rome). 2021 May;22(5):1-105. doi: 10.1714/3605.35841. Italian. PMID: 34741593.
Copy Download .nbib Format: NLM
Aspirin, NOACs, Warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021.

European heart journal. Cardiovascular pharmacotherapy

Mone P, Trimarco B, Santulli G.
PMID: 34849683
Eur Heart J Cardiovasc Pharmacother. 2021 Nov 26; doi: 10.1093/ehjcvp/pvab081. Epub 2021 Nov 26.

No abstract available.

Cite
Mone P, Trimarco B, Santulli G. Aspirin, NOACs, Warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021. Eur Heart J Cardiovasc Pharmacother. 2021;doi: 10.1093/ehjcvp/pvab081.
Mone, P., Trimarco, B., & Santulli, G. (2021). Aspirin, NOACs, Warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021. European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvab081
Mone, Pasquale, et al. "Aspirin, NOACs, Warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021." European heart journal. Cardiovascular pharmacotherapy vol. (2021). doi: https://doi.org/10.1093/ehjcvp/pvab081
Mone P, Trimarco B, Santulli G. Aspirin, NOACs, Warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021. Eur Heart J Cardiovasc Pharmacother. 2021 Nov 26; doi: 10.1093/ehjcvp/pvab081. Epub 2021 Nov 26. PMID: 34849683.
Copy Download .nbib Format: NLM
Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet.

Mediterranean journal of nutrition and metabolism

Trimarco B, Benvenuti C, Rozza F, Cimmino CS, Giudice R, Crispo S.
PMID: 21909461
Med J Nutrition Metab. 2011 Aug;4(2):133-139. doi: 10.1007/s12349-010-0043-6. Epub 2011 Feb 03.

Efficacy of a new patented proprietary combination of natural nutraceuticals (PN) containing natural hypolipidemic as red yeast, policosanol and berberine was tested in a large study on dyslipidemic patients in clinical practice. A parallel, controlled, randomized, multicenter study was...

Cite
Trimarco B, Benvenuti C, Rozza F, et al. Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet. Med J Nutrition Metab. 2011;4(2):133-139doi: 10.1007/s12349-010-0043-6.
Trimarco, B., Benvenuti, C., Rozza, F., Cimmino, C. S., Giudice, R., & Crispo, S. (2011). Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet. Mediterranean journal of nutrition and metabolism, 4(2), 133-139. https://doi.org/10.1007/s12349-010-0043-6
Trimarco, Bruno, et al. "Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet." Mediterranean journal of nutrition and metabolism vol. 4,2 (2011): 133-139. doi: https://doi.org/10.1007/s12349-010-0043-6
Trimarco B, Benvenuti C, Rozza F, Cimmino CS, Giudice R, Crispo S. Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet. Med J Nutrition Metab. 2011 Aug;4(2):133-139. doi: 10.1007/s12349-010-0043-6. Epub 2011 Feb 03. PMID: 21909461; PMCID: PMC3151482.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 86 entries